Drug
0.01% atropine eye drops
0.01% atropine eye drops is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
3
75%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
completed250%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruitingnot_applicable
Early-Onset Myopia Intervention Project
NCT07176949
recruitingnot_applicable
A-eyedrops on Ocular Alignment and Binocular Vision
NCT05379855
completednot_applicable
Combined Atropine With Orthokeratology in Childhood Myopia Control (AOK) -A Randomized Controlled Trial
NCT02955927
completedphase_1
Effects of Low Concentration Atropine on Pupillary Size and Accommodative Amplitude
NCT03699423
Clinical Trials (4)
Showing 4 of 4 trials
NCT07176949Not Applicable
Early-Onset Myopia Intervention Project
NCT05379855Not Applicable
A-eyedrops on Ocular Alignment and Binocular Vision
NCT02955927Not Applicable
Combined Atropine With Orthokeratology in Childhood Myopia Control (AOK) -A Randomized Controlled Trial
NCT03699423Phase 1
Effects of Low Concentration Atropine on Pupillary Size and Accommodative Amplitude
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4